Investigational Pharmacy Service at BMC

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Maintenance, Management and Monitoring of Investigational Supply
Tips to a Successful Monitoring Visit
Inpatient Medication Inventory Management: Ward Stock
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Good Clinical Practices Regulatory Guidelines for the Conduct of Clinical research Introduction to Research Pharmacy Services Javier Palacios, R.Ph. Sponsored.
YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Special Topics in IND Regulation
Determining % Effort for Clinical Trial Kathy Price, RN, MBA Manager, GI Clinical Research.
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
PRE-AWARD PAPERWORK FOR CLINICAL TRIALS SERIES 4, SESSION 8 OCTOBER 28, 2014 Applicants and Administrators Pre-Award Luncheon Series.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Andrew Schoch Pharmacy Intern Northeastern University Class of 2010
INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center
The pharmacist: at the heart of the research protocols Marie-Pascale Guay, B. Pharm, M. Sc. Julie Roy, B.Pharm, PhD. Jewish General Hospital November 10,
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Monitoring and Special Considerations for Multi-Center Trials
Foundation Financial Services Post Award Nancy Gomez Post Award Analyst.
Merrell Lim, Pharm.D. Investigational Drug Services Pharmacist
Yesterday, today, and tomorrow
Investigational New Drug Application (IND)
Office of Clinical Research and Innovative Care Compliance (OCRICC) What You Need To Know About Conducting Research at Froedtert Hospital Roberta Navarro,
When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.
INDs : Does My Study Need One? Edith Paal UAMS Office of Research Compliance August 22, 2003.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Budget Development Presented by: Jean Mercer Associate Director for Clinical Research Administration Office of Clinical Research – School of Medicine.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
1 January 17, 2008 Test Article Accountability. 2 January 17, 2008 Investigator Responsibilities 21 CFR  Maintain control of drug under investigation.
Reimbursement Statements What you need to know. Let’s Take a Closer Look… …at invoicing, cost ledgers, SB and budget revisions.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Emtenan AlHarbi,Mcs Clinical pharmacist
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
Investigational Devices and Humanitarian Use Devices June 2007.
How to Start An Industry Sponsored Clinical Trial
CTMB Guidelines (Rev. October 2006) Section 5: Conducting the Quality Assurance Audit.
IP Accountability in Outpatient Clinical Trials
Clinical Research Coordinator Fundamentals Course Remuneration (Clincard) Laura Vinci, RN, MBA Senior Director of Operations Jefferson Clinical Research.
Sponsor Visits and Monitoring
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
IP Accountability in Outpatient Clinical Trials Jessica Rinaldi, CCRP Farber Institute for Neurosciences.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Research Approval Workflow EPIC Optimization
Clinical Trial Budgets
PRCSG Training Webinar: Budget for Industry Sponsored Studies
The Role and Responsibilities of the Clinical Research Coordinator
Setting Up a New Recharge Center
Training for Investigators and Research Personnel
Responsibilities of Sponsor, Investigator and Monitor
Clinical Resources: LLUMC Investigational Drug Service
Study Feasibility and Start-up
MAINTAINING THE INVESTIGATOR’S SITE FILE
Operationalizing Your Study At Grady
Structure of Industry Budgets
Bozeman Health Clinical Research
Training for Investigators and Research Personnel
Elements of an Organized Regulatory Binder
Getting a Study Done at Jefferson:
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Clinical Trial Budgets
PEARLS Overview and Research Team Management
Controlled Substances
OSU Controlled Substances Training Module for Researchers
MOST Study Update and Protocol Refresher
Office of Grants and Contracts Presenter: Stephanie Chandler-Thompson
Presentation transcript:

Investigational Pharmacy Service at BMC IPS Budgeting Process Stephen Zalewski, PharmD, CCRC

What is the Role of IPS at BMC? Provide support for all clinical drug studies conducted at BU/BMC. Responsible for the Receipt, Storage, Dispensing and Disposition of all research-related drug products. Ensure the investigational products are used appropriately to maximize study participant safety and mitigate any unnecessary risks. Ensure compliance with applicable regulatory and protocol requirements regarding the use of investigational products. Provide additional support to study teams related to research (randomization, drug accountability and disposition, blinding/unblinding, etc.)

What is a Drug? FDA definition of Drug – A substance recognized by an official pharmacopoeia or formulary. A substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. A substance (other than food) intended to affect the structure or any function of the body. Prescription medications Nutraceuticals Contrast agents Over-the-counter (OTC) drugs Vaccines Herbal remedies Diagnostic Sample medications Vitamins

What is an Investigational Drug? A drug that is being studied and that has not yet received permission from the U.S. Food and Drug Administration to be legally marketed and sold in the United States. New drug or already approved New strength or combination New dosage form New route of administration New disease New population Investigational use of a commercial product Ancillary or auxiliary drugs that are protocol-required.

What Services Does IPS Offer? Protocol Review and Editing Dispensing and Accountability Study Start-Up/Close-Out Randomization Institutional Logistics and Operations Blinding Inventory Control Compounding Storage – temperature monitoring Repackaging Drug Information Collaborating with monitors and auditors for site and remote visits. Assist with database maintenance (Vestigo, EPIC) Providing tours for site qualification visits Pharmacy Binders IRB membership Institutional Logistics and Operations Collaborate with lab, nursing, finance, CTO, IT, GCRU, etc.

When should we contact IPS with a new project? As Early As Possible!

IPS Involvement with a New Project Review of protocol/draft to determine feasibility Determine the scope of the project Inpatient vs Outpatient vs Ambulatory Infusion Center Clinic setting vs GCRC 24h/7d enrollment Nursing/Pharmacy training needs IPS cost analysis Project timelines

Preparing a IPS Budget IPS Protocol Planning Worksheet IPS Budget Worksheet IPS Budget Agreement

IPS Protocol Planning Worksheet Sponsor:   Sponsor’s Protocol Number: Protocol Title: Investigator: Phone: Pager: Department: Fund Management (BU or BMC) Study Coordinator: Items you’re submitting:  Protocol  Summary  Other: Information you need from IPS:  Cost Estimate - Timeline:  ASAP  within 2 weeks  Schedule a pre-study visit or planning meeting (Explain): Tell us about the study: How many subjects are you planning to enroll? Anticipated start date: Treatment duration: Overall study duration: Where will subjects be seen or dosed? Has the study been submitted to IRB? If so, provide #: IF KNOWN, does the sponsor require any specialized training sessions, webinars, etc? Do any medications or supplies need to be purchased? What medications/supplies will be provided free through sponsor? Any special manufacturing/compounding/formulation needed? Any special packaging requested? Will IPS be involved with other sites (distribution, coordination, etc)? Any other important information? IPS Protocol Planning Worksheet

INVESTIGATIONAL PHARMACY SERVICE (IPS) PROTOCOL BUDGET WORKSHEET Est. Start Date:   Prescription Complexity: Level (see Section A) Duration: months Number of Rx’s/Study Visit: Rx’s Target Enrollment: subjects Number of Visits/Treatment Arm: visits/Arm FIXED FEES – Onetime fee charged at the beginning of the study that includes but is not limited to the following: STUDY INITIATION FEE (~12 hours) Meeting with study personnel — both in-house and sponsor — prior to the start of the study IPS Protocol Binder setup Preparation of pharmacy-specific protocol guidelines Arranging for shipment of study drug and determining space requirements Creation of study file(s) and associated drug file(s) in the IPS computer system STUDY CLOSEOUT FEE (~4 hours) Final accountability logs, Meeting with study monitor for determination of final disposition of study materials Computer system maintenance Document archiving 16 hour = $xxx.xx (rate $xx/hr) Fixed fee. DISPENSING FEES – These fees vary and depend on the type of dispensing: Dispensing fee per enrollment A x rate x B x C = $ xxx.xx Dispensing fee for entire study A x rate x B x C x D Variable fee based on enrollment. A Level 1 Oral, Topical, Inhalation, pre-filled syringes, vials for home use Unit of Use dispensing (inpatient and outpatient) Protocol-required meds that are not Standard of Care (SOC) 30min Level 2 IV doses (chemotherapy and non-chemotherapy) Doses requiring reconstitution LVP, IVPB or syringes Controlled Substances Complex accountability documentation May include protocol-required meds that are not SOC 45min Level 3 More complex than basic Level 1&2 preparations 60min Level 4 To be determined by the protocol, eg Rx-specific blinding, compounding, etc. TBD B Number of prescriptions per Study Visit C Number of Study Visits/Treatment Arm D Number of subjects enrolled MONTHLY ADMINISTRATIVE FEES – These fees reflects time spent: Maintaining inventory levels and storage areas Ordering necessary supplies and disposal of expired or unused supplies Meeting with study monitors and auditors Updating procedures and regulatory documents as protocol is amended 0.5 hr/month x rate = $xxx.xx/month x X months = $xxx.xx Variable fee based study duration. FEES FOR SPECIAL SERVICES – Variable fees study specific. Randomization schedules Creating blinding procedures Coordinating drug use between multiple sites Prepacking Compounding Drug purchases IPS Budget Worksheet

IPS Budget Agreement

BMC Study Revenue Cycle IPS Produces Quarterly Vestigo Invoices Research Team Bills Sponsor BMC Accounting Debits charges from Lawson Credits payment into Lawson Notifies IPS of JE # BMC Study Revenue Cycle

BU Study Revenue Cycle BMC Accts Receivable BMC Accounting IPS Produces Quarterly Vestigo Invoices Research Team Bills the Sponsor BMC Accounting Creates a BMC invoice w/supporting documents Research Team/BU AP Credits payment into BU Account BU Accts Payable Bills the sponsor Sends a check to BMC BMC Accts Receivable Posts check to IPS BU Study Revenue Cycle

Any Questions? IPS@BMC.org Thank you! Any Questions? IPS@BMC.org